Evan Beckman
Novartis (United States)(US)
Publications by Year
Research Areas
Immune Cell Function and Interaction, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, Immune Response and Inflammation, Heart Failure Treatment and Management
Most-Cited Works
- → Recognition of a lipid antigen by CD1-restricted αβ+ T cells(1994)972 cited
- → TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study(2007)829 cited
- → Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells(1995)461 cited
- → Structural Requirements for Glycolipid Antigen Recognition by CD1b-Restricted T Cells(1997)433 cited
- → BG9719 (CVT-124), an A 1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy(2002)370 cited
- → Genome-Wide Association Scan Identifies Candidate Polymorphisms Associated with Differential Response to Anti-TNF Treatment in Rheumatoid Arthritis(2008)211 cited
- → CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family(1996)210 cited
- CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool.(1999)
- → CD1-Restricted Microbial Lipid Antigen-Specific Recognition Found in the CD8+ αβ T Cell Pool(1999)195 cited
- → Effects of BG9719 (CVT-124), an A1-Adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure(2000)147 cited